NeoGenomics, Inc. Liabilities, Noncurrent
NeoGenomics, Inc. (NEO) had Liabilities, Noncurrent of $460.63 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2026-07-28
- 2026-06-30: Liabilities, Noncurrent $460.63M.
- 2026-03-31: Liabilities, Noncurrent $433.18M.
- 2025-12-31: Liabilities, Noncurrent $434.97M.
- 2025-09-30: Liabilities, Noncurrent $438.62M.
| Period end | Liabilities, Noncurrent | Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $460.63M 10-Q · filed 2026-07-28 | |
| 2026-03-31 | $433.18M 10-Q · filed 2026-04-28 | |
| 2025-12-31 | $434.97M 10-Q · filed 2026-07-28 | |
| 2025-09-30 | $438.62M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $439.79M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $433.47M 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $434.46M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $436.50M 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $437.43M 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $640.22M 10-Q · filed 2024-04-30 | |
| 2023-12-31 | $643.39M 10-K · filed 2025-02-18 | |
| 2023-09-30 | $637.89M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $644.07M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $648.11M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $652.08M 10-K · filed 2024-02-20 | |
| 2022-09-30 | $657.59M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $665.92M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $672.47M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $674.27M 10-K · filed 2023-02-24 | |
| 2021-09-30 | $676.40M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $648.82M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $582.95M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $220.85M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $228.45M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $229.56M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $159.56M 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $138.19M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $145.24M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $147.77M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $136.79M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $123.65M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $104.53M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $133.60M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $97.95M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $103.41M 10-K · filed 2019-02-26 | $102.74M 10-K · filed 2018-03-13 |
| 2017-09-30 | $104.12M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $108.10M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $109.74M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $112.41M 10-K · filed 2018-03-13 | |
| 2016-09-30 | $73.94M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $73.23M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $72.36M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $73.12M 10-K · filed 2017-03-14 | $89.78M 10-K · filed 2016-03-15 |
| 2015-09-30 | $6.56M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $6.97M 10-Q · filed 2015-07-31 | |
| 2015-03-31 | $7.15M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $6.08M 10-K · filed 2016-04-18 | |
| 2014-09-30 | $5.80M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $5.28M 10-Q · filed 2014-07-29 | |
| 2014-03-31 | $4.60M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $3.88M 10-K · filed 2015-03-03 | |
| 2012-12-31 | $3.10M 10-K · filed 2014-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |